Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research -Skierniewice, Poland

Verified

Basic Information

Site Overview

Source: Human-provided.

Velocity Clinical Research's site in Skierniewice, Poland, was established in 2000 as ClinMedica Research and acquired by Velocity in 2023. As the largest clinical research facility in the region, the site specializes in conducting Phase II-IV clinical trials across a wide range of therapeutic areas, including cardiology, dermatology, pulmonology, endocrinology, metabolic diseases, gastroenterology, and population-based vaccine studies. Recognized for its strong reputation and exceptional patient care, Velocity Skierniewice is highly regarded by sponsors and contract research organizations (CROs). The site maintains close ties with Ogrodowa Medical Center and local communities, allowing for fast and accurate patient recruitment, even for diverse populations. With a commitment to advancing medicine through research, the Skierniewice team combines decades of experience with high-quality, compassionate patient care to support a broad array of clinical studies.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Research institute

Business Subcategory

Source: Google. Research institute
Source: Trial-derived.
8Total Trials
Source: Trial-derived.
4Recruiting Trials
Source: Trial-derived.
6Active Trials
Source: Trial-derived.
2Completed Trials
Source: Trial-derived.
5Unique Conditions
Source: Trial-derived.
6Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Plaque Psoriasis (3)Source: Trial-derived. Heart Failure (2)Source: Trial-derived. NonSegmental Vitiligo (1)Source: Trial-derived. Obesity (1)Source: Trial-derived. Ulcerative Colitis (1)

Sponsors

Source: Trial-derived. Boehringer Ingelheim (3)Source: Trial-derived. Alumis Inc (1)Source: Trial-derived. Bristol-Myers Squibb (1)Source: Trial-derived. Genentech, Inc. (1)Source: Trial-derived. Incyte Corporation (1)Source: Trial-derived. Janssen Research & Development, LLC (1)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Specimen packaging and shipment

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance